Overview

Steroids After Spine Fusion Surgery

Status:
Not yet recruiting
Trial end date:
2023-10-06
Target enrollment:
0
Participant gender:
All
Summary
This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Oregon Health and Science University
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Prednisone
Criteria
Inclusion Criteria:

- All patients over the age of 50 undergoing thoracic and/or lumbar fusion with a Spine
Center surgeon will be included

Exclusion Criteria:

- Patient is already taking chronic steroids

- Patient is pregnant

- Patient is decisionally impaired

- Patient is a prisoner